DuPont falls on earnings, but investors might want to buy on weakness

The market didn't like DuPont's (DD) third-quarter earnings report, sending shares of the chemical giant down as much as three percent during Tuesday's session. This component of the Dow Jones Industrial Average ($INDU) easily beat Wall Street's profit estimate, but sales across all DuPont's businesses were down.

DuPont's stock has been a market beater so far this year, rising 37 percent to outpace the S&P 500 ($INX) by 15 percentage points. Perhaps today's stumble offers investors a chance to buy the blue chip on weakness. Shares go for just 16 times forward earnings, offering a discount of about 20 percent to the broader market. That's an intriguing relative valuation. Perhaps most attractive is DuPont's dividend. The share-price slide has boosted the yield to 4.8 percent.
Read Full Story

Markets

DJIA 24,753.09 -58.67 -0.24%
NASDAQ 7,433.85 9.43 0.13%
NIKKEI 225 22,450.79 13.78 0.06%
HANG SENG 30,588.04 -172.37 -0.56%
DAX 12,938.01 82.92 0.65%
USD (per EUR) 1.17 -0.01 -0.59%
USD (per CHF) 0.99 0.00 -0.17%
JPY (per USD) 109.41 0.10 0.09%
GBP (per USD) 1.33 -0.01 -0.56%